Nathan Fountain

Nathan Fountain

Directeur/Membre du Conseil chez ACUMEN PHARMACEUTICALS, INC.

Fortune : 128 561 $ au 30/06/2026

63 ans
Consumer Services
Commercial Services
Health Technology

Profil

Nathan B. Fountain is President & Chief Executive Officer at Hexokine Therapeutics, Inc. since 2021.
Dr. Fountain serves as Chairman-Research Roundtable for Epilepsy at the Epilepsy Foundation.
Dr. Fountain is an Independent Director at Acumen Pharmaceuticals, Inc. since 2021.
Dr. Fountain is Director-FE Dreifuss Comprehensive Epilepsy at the University of Virginia since 1998.
Dr. Fountain is a Professor at The University of Virginia School of Medicine.
Former roles include Director at Marmot Mountain, LLC (New York) and President & Director at the National Association of Epilepsy Centers.
Education includes undergraduate studies at the University of Iowa and a doctorate from the University of Iowa Carver College of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/06/2026 48 150 ( 0,07 % ) 128 561 $ 30/06/2026

Postes actifs de Nathan Fountain

SociétésPosteDébut
ACUMEN PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/06/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Hexokine Therapeutics, Inc.
Directeur Général 01/11/2021
Corporate Officer/Principal 01/01/1998

Anciens postes connus de Nathan Fountain

SociétésPosteFin
Directeur/Membre du Conseil -
President -
Voir l'expérience en détail de Nathan Fountain

Formation de Nathan Fountain

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Consumer Services

Consumer Services

Commercial Services

Retail Trade

Consumer Services

Consumer Services

Commercial Services

Hexokine Therapeutics, Inc.

  1. Bourse
  2. Insiders
  3. Nathan Fountain
🔇